Alpine Immune Sciences Inc. (NASDAQ:ALPN): Samuel Isaly’s OrbiMed Advisors filed an amended 13D.
You can check out OrbiMed Advisors’ latest holdings and filings here.
Please follow OrbiMed Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about OrbiMed Advisors or update its stock holdings.
Follow Sam Isaly's OrbiMed Advisors
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
OrbiMed Advisors | 0 | 3,298,516 | 0 | 3,298,516 | 3,298,516 | 23.76% |
OrbiMed Capital GP VI | 0 | 3,298,516 | 0 | 3,298,516 | 3,298,516 | 23.76% |
Follow Sam Isaly's OrbiMed Advisors
Page 1 of 9 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Under the Securities Exchange Act of 1934
Common Stock, par value $0.001 per share
OrbiMed Capital GP VI LLC
New York, NY 10022
Telephone: (212) 739‑6400
Authorized to Receive Notices and Communications)
January 24, 2018
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 2 of 9 – SEC Filing
CUSIP No. 02083G100 | ||||
1 | NAME OF REPORTING PERSONS OrbiMed Advisors LLC | |||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ☐ (b) ☐ | |||
3 | SEC USE ONLY | |||
4 | SOURCE OF FUNDS (See Instructions) AF | |||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | ||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | |||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | ||
8 | SHARED VOTING POWER 3,298,516 | |||
9 | SOLE DISPOSITIVE POWER 0 | |||
10 | SHARED DISPOSITIVE POWER 3,298,516 | |||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,516 | |||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | ||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.76% * | |||
14 | TYPE OF REPORTING PERSON (See Instructions) IA |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 3 of 9 – SEC Filing
CUSIP No. 02083G100 | |||||
1 | NAME OF REPORTING PERSONS OrbiMed Capital GP VI LLC | ||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ☐ (b) ☐ | ||||
3 | SEC USE ONLY | ||||
4 | SOURCE OF FUNDS (See Instructions) AF | ||||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | |||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | |||
8 | SHARED VOTING POWER 3,298,516 | ||||
9 | SOLE DISPOSITIVE POWER 0 | ||||
10 | SHARED DISPOSITIVE POWER 3,298,516 | ||||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,516 | ||||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | |||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.76%* | ||||
14 | TYPE OF REPORTING PERSON (See Instructions) OO |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 4 of 9 – SEC Filing
Item 1. | Security and Issuer |
Item 2. | Identity and Background |
Item 5. | Interest in Securities of the Issuer |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 5 of 9 – SEC Filing
Item 6. | Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer |
Item 7. | Materials to Be Filed as Exhibits |
Exhibit | Description |
1. | Joint Filing Agreement among OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC. |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 6 of 9 – SEC Filing
OrbiMed Advisors LLC | ||||
By: | /s/ Jonathan T. Silverman | |||
Name: | Jonathan T. Silverman | |||
Title: | Member of OrbiMed Advisors LLC | |||
By: | /s/ Sven H. Borho | |||
Name: | Sven H. Borho | |||
Title: | Member of OrbiMed Advisors LLC | |||
By: | /s/ Carl L. Gordon | |||
Name: | Carl L. Gordon | |||
Title: | Member of OrbiMed Advisors LLC | |||
OrbiMed Capital GP VI LLC | ||||
By: | OrbiMed Advisors LLC its managing member | |||
By: | /s/ Jonathan T. Silverman | |||
Name: | /s/ Jonathan T. Silverman | |||
Title: | Member of OrbiMed Advisors LLC | |||
By: | /s/ Sven H. Borho | |||
Name: | Sven H. Borho | |||
Title: | Member of OrbiMed Advisors LLC | |||
By: | /s/ Carl L. Gordon | |||
Name: | Carl L. Gordon | |||
Title: | Member of OrbiMed Advisors LLC | |||
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 7 of 9 – SEC Filing
Name | Position with Reporting Person | Principal Occupation |
Samuel D. Isaly | Managing Member | Managing Member OrbiMed Advisors LLC |
Carl L. Gordon | Member | Member OrbiMed Advisors LLC |
Sven H. Borho German and Swedish Citizen | Member | Member OrbiMed Advisors LLC |
Jonathan T. Silverstein | Member | Member OrbiMed Advisors LLC |
W. Carter Neild | Member | Member OrbiMed Advisors LLC |
Geoffrey C. Hsu | Member | Member OrbiMed Advisors LLC |
Evan D. Sotiriou | Chief Financial Officer | Chief Financial Officer OrbiMed Advisors LLC |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 8 of 9 – SEC Filing
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 9 of 9 – SEC Filing
Exhibit | Description |
1. | Joint Filing Agreement among OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC. |
9